News
CAM Investigator Dr. Jodi Gilman Named MGH Scholar Award Recipient
We are pleased to announce that Dr. Jodi Gilman has been selected as a recipient of the prestigious MGH Research Scholars Award. This highly competitive program provides unrestricted funding to outstanding investigators whose innovative research may not yet be eligible for traditional funding sources such as the NIH. Dr. Gilman’s research focuses on using advanced…MORE
CAM Publication Highlighted on the June 2025 Edition of The Recovery Bulletin
Dr. Evins & Dr. Schuster’s recent publication “Varenicline for youth nicotine vaping cessation: A randomized clinical trial” was selected for inclusion in the June 2025 edition of the MGH Research Recovery Institute’s Recovery Bulletin which hand selects articles based on their relevance, scientific rigor, and potential to drive meaningful progress in recovery outcomes. View the…MORE
Smoking Cessation Drug Varenicline Helps Young Adults Quit Vaping
Congratulations to Dr. Eden Evins, Dr. Randi Schuster, and CAM staff who recently published a study which showed that teens and young adults who took Varenicline—an FDA-approved, twice-daily smoking cessation pill for adults—are more than three times as likely to successfully quit vaping compared to those who received only behavioral counseling. See further details published…MORE
Helping People With Serious Mental Illness Quit Smoking
Dr. Eden Evins and colleagues recently published a study examining the efficacy of an 18-month community-based tobacco smoking cessation intervention. The intervention consisted of both pharmacologic (Varenicline, dual-form nicotine replacement, or their combination) and behavioral components (tailored individual and group counseling for motivational enhancement; smoking cessation and relapse prevention; weight management counseling and support for…MORE
Recent CAM/Johns Hopkins Medicine Collaboration Receiving Media Attention!
CAM staff Dr. Eden Evins and Dr. Corrine Cather recent research article, published in collaboration with Johns Hopkins Medicine, has been receiving media attention from various news outlets including US News, AJMC, and Drugs.com. You can read the articles through the links below. US News: Program Helps Folks Battling Mental Illness Beat Another Foe: Smoking…MORE
Center for Addiction Medicine and Johns Hopkins Medicine Collaboration
CAM staff Dr. Eden Evins and Dr. Corrine Cather, in collaboration with staff Johns Hopkins Medicine recently published an article examining the effect of a tobacco intervention incorporating weight management for adults with serious mental illness. This randomized clinical trial investigates if an 18-month tobacco-smoking cessation intervention including weight management is effective in adults with…MORE
Substance Use Disorders: A Comprehensive Review and Update
We invite you to join us at Disney’s BoardWalk Inn or Virtually February 19-21, 2024 Substance use disorders are complex and have a huge impact on patients, families and communities. They challenge even experienced health care professionals to stay current with evolving guidelines and they are seen and treated across all professions, disciplines and practice settings including…MORE
Call for Applications – K12 Fellowship
DOWNLOAD APPLICATION HERE *The application process is currently closed. Please visit this page at a later time for updates MGH Career Development Program in Substance Use and Addiction Medicine Call for Applications (Pictured right, Spring 2018 K12 Scholar, Kate Bentley, PhD) We are delighted to announce the renewal of this NIDA-sponsored K12 Mentored Clinician Scientist…MORE
CAM Director Eden Evins Meets with the US Surgeon General
Center for Addiction Medicine Director Dr. Eden Evins recently met with Surgeon General Vivek Murthy, Senator Ed Marky, and Dr. Sue Gabrieli to discuss the Surgeon General Advisory Report on kids and mental health as well as discussing the current work being done in the center.
MGH Psychiatry Faculty To Direct 2024 Substance Use Disorder Conference
The MGH Psychiatry Academy faculty invite you to join us at Disney’s Grand Floridian Resort & Spa for our annual Substance Use Disorder conference, held on February 19, 2024 to February 21, 2024. Substance use disorders are complex and have a huge impact on patients, families and communities. They challenge even experienced health care professionals…MORE